Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Theragen
    Junior Member
    • Oct 2015
    • 2

    Looking for NGS agent in Europe

    Our company is a NGS sequencing provider company.
    We need who has NGS connections for sequencing service.
    We are looking for NGS agents(or individual), who can connect NGS services to Europe customers who needs NGS services.

    Our NGS Service type:

    (Shipping+ Library+sequencing+ Data analysis BI(Bioinformatics analysis))

    <Next Generation Sequencing> Our service includes (Shipping + QC + Library construction + sequencing + BI Data analysis(FTP Link))

    Whole exome, RNA-seq, Whole genome sequencing, targeted sequencing, methyl-seq, Genotyping Microarray, NIPT (Non Invasive Prenatal Test) service
    Platform: Illumina HiSeq 2500/4000, Ion Torrent, PGM, PGM DX.
    We are now aiming to make a mark on the global market by showcasing our products and services in Europe. we are concentrating & looking for the business partner who are operating in Europe .

    We guarantee the highest (Q30 > higher than 85%) value compare to all other NGS providers in the world.
    We provide the shortest TAT(Turn around time) in NGS market compare to other NGS sequencing providers.
    We have LIMS online system for tracking sample process.
    For further questions, please contact to sarang.kim[at]theragenetex.com



    Required experience:

    NGS Technology: 1 year
    Required language: English

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
11 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...